IT1177381B - Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive - Google Patents

Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive

Info

Publication number
IT1177381B
IT1177381B IT23998/84A IT2399884A IT1177381B IT 1177381 B IT1177381 B IT 1177381B IT 23998/84 A IT23998/84 A IT 23998/84A IT 2399884 A IT2399884 A IT 2399884A IT 1177381 B IT1177381 B IT 1177381B
Authority
IT
Italy
Prior art keywords
conjugates
monophosphate
adenine
beta
preparation
Prior art date
Application number
IT23998/84A
Other languages
English (en)
Other versions
IT8423998A1 (it
IT8423998A0 (it
Inventor
Luigi Fiume
Corrado Busi
Alessandro Mattioli
Massimo Baldacci
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Publication of IT8423998A0 publication Critical patent/IT8423998A0/it
Priority to IT23998/84A priority Critical patent/IT1177381B/it
Priority to CA000497300A priority patent/CA1252719A/en
Priority to US06/807,657 priority patent/US4794170A/en
Priority to DE198585115802T priority patent/DE184838T1/de
Priority to JP60278843A priority patent/JPH0633320B2/ja
Priority to AU51186/85A priority patent/AU576923B2/en
Priority to ES549828A priority patent/ES8704945A1/es
Priority to DE8585115802T priority patent/DE3574707D1/de
Priority to AT85115802T priority patent/ATE48612T1/de
Priority to EP85115802A priority patent/EP0184838B1/en
Publication of IT8423998A1 publication Critical patent/IT8423998A1/it
Application granted granted Critical
Publication of IT1177381B publication Critical patent/IT1177381B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
IT23998/84A 1984-12-11 1984-12-11 Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive IT1177381B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT23998/84A IT1177381B (it) 1984-12-11 1984-12-11 Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive
CA000497300A CA1252719A (en) 1984-12-11 1985-12-10 METHOD FOR THE PREPARATION OF CONJUGATES OF ADENINE-9- .beta.-ARABINOFURANOSIDE 5' MONOPHOSPHATE WITH LACTOSAMINATED HUMAN ALBUMIN, THE CONJUGATES OBTAINED AND THERAPEUTICALLY ACTIVE COMPOSITION CONTAINING THEM
JP60278843A JPH0633320B2 (ja) 1984-12-11 1985-12-11 ラクトサミン化ヒトアルブミンとアデニン―９―β―Ｄ―アラビノフラノシド５′モノホスフェートの結合体の製造方法
DE198585115802T DE184838T1 (de) 1984-12-11 1985-12-11 Konjugate von adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
US06/807,657 US4794170A (en) 1984-12-11 1985-12-11 Method for the preparation of conjugates of adenine-9-beta-arabinofuranoside 5' monophosphate with lactosaminated human albumin, the obtained conjugates and therapeutically active compositions containing them
AU51186/85A AU576923B2 (en) 1984-12-11 1985-12-11 Conjugates of adenine-9-beta-arabinofuranoside-5- monophosphate and lactosaminated human albumin
ES549828A ES8704945A1 (es) 1984-12-11 1985-12-11 Procedimiento de preparar conjugados de adentina 9-beta-d-arabinofuranosido 5' monofosfato con albumina humana lactosaminada.
DE8585115802T DE3574707D1 (de) 1984-12-11 1985-12-11 Konjugate von adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
AT85115802T ATE48612T1 (de) 1984-12-11 1985-12-11 Konjugate von adenin-9-beta-arabinofuranosid-5'monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
EP85115802A EP0184838B1 (en) 1984-12-11 1985-12-11 Conjugates of adenine-9-beta-arabinofuranoside 5' monophosphate with lactosaminated human albumin, a method for their preparation and therapeutically active compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23998/84A IT1177381B (it) 1984-12-11 1984-12-11 Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive

Publications (3)

Publication Number Publication Date
IT8423998A0 IT8423998A0 (it) 1984-12-11
IT8423998A1 IT8423998A1 (it) 1986-06-11
IT1177381B true IT1177381B (it) 1987-08-26

Family

ID=11211397

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23998/84A IT1177381B (it) 1984-12-11 1984-12-11 Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive

Country Status (9)

Country Link
US (1) US4794170A (it)
EP (1) EP0184838B1 (it)
JP (1) JPH0633320B2 (it)
AT (1) ATE48612T1 (it)
AU (1) AU576923B2 (it)
CA (1) CA1252719A (it)
DE (2) DE184838T1 (it)
ES (1) ES8704945A1 (it)
IT (1) IT1177381B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1207507B (it) * 1985-10-21 1989-05-25 Baldacci Lab Spa Coniugato della 9-(2-idrossietossimetil)guanina con albumina umana lattosaminata, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
IT1245217B (it) * 1991-03-12 1994-09-13 Baldacci Lab Spa Coniugato di azidotimidina ed albumina umana procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IT1256110B (it) * 1992-11-23 1995-11-28 Procedimento di coniugazione di nucleosidi antivirali con albumina umana lattosaminata
ITMI20010027A1 (it) * 2001-01-10 2002-07-10 Uni Di Bologna Dipartimento Di Composizioni teraputiche per una chemioterapia locoregionale non invasiva delle micrometastasi epatiche
JP2006518727A (ja) * 2003-02-17 2006-08-17 アッパートン リミテッド キャリヤー、ターゲッティング部分、および造影剤を含んでいる医療用イメージングのための接合体

Also Published As

Publication number Publication date
EP0184838A3 (en) 1987-04-29
ES549828A0 (es) 1987-05-01
JPH0633320B2 (ja) 1994-05-02
EP0184838A2 (en) 1986-06-18
CA1252719A (en) 1989-04-18
EP0184838B1 (en) 1989-12-13
JPS61171430A (ja) 1986-08-02
ATE48612T1 (de) 1989-12-15
DE3574707D1 (de) 1990-01-18
US4794170A (en) 1988-12-27
ES8704945A1 (es) 1987-05-01
IT8423998A1 (it) 1986-06-11
AU576923B2 (en) 1988-09-08
AU5118685A (en) 1986-06-19
IT8423998A0 (it) 1984-12-11
DE184838T1 (de) 1987-03-19

Similar Documents

Publication Publication Date Title
HUT60512A (en) Process for producing polyethylene glycol conjugates of proteins
AU645747B2 (en) A novel antibody delivery system for biological response modifiers
NO885199L (no) Fremgangsmaate for fremstilling av monoklonale antistoffkonjugater.
KR890700162A (ko) 재조합 슈도모나스 외독소, 이를 포함한 부작용이 낮은 활성 면역독소 및 이의 제조방법
WO1998022141A3 (en) Enhanced effects for hapten conjugated therapeutics
IT8423998A1 (it) Metodo per la preparazione di coniugati della adenina-9- B -D-arabino furanoside 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioni terapeuticamente attive
FI891718A0 (fi) Foerfarande foer att befria cellblandningar och vaevnader av icke-oenskade populationer.
DK148586A (da) Fremgangsmaade til fremstilling af konjugater af metal-lothionein og biologisk aktive molekyler
ATE76877T1 (de) Hapten-protein-konjugate und ihre verwendung.
ATE75487T1 (de) Langwirkende immunotoxine, die eine ribosominaktivierende, an ihren polysaccharidstellen modifizierte glycopeptidsubstanz umfassen.
RU97120930A (ru) Конъюгаты полимиксина
IT1207507B (it) Coniugato della 9-(2-idrossietossimetil)guanina con albumina umana lattosaminata, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.
ES2004734A6 (es) Procedimiento de obtencion de conjugados biologicamente activos de metaloproteina-albumina o metaloproteina-albumina-anticuerpos
IT1245217B (it) Coniugato di azidotimidina ed albumina umana procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961227